These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26427016)

  • 1. Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells.
    Khumalo T; Ferreira E; Jovanovic K; Veale RB; Weiss SF
    PLoS One; 2015; 10(10):e0139584. PubMed ID: 26427016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases.
    Rebelo TM; Vania L; Ferreira E; Weiss SFT
    Exp Cell Res; 2018 Jul; 368(1):1-12. PubMed ID: 29653110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18.
    Khumalo T; Reusch U; Knackmuss S; Little M; Veale RB; Weiss SF
    PLoS One; 2013; 8(6):e66297. PubMed ID: 23823499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
    Vania L; Rebelo TM; Ferreira E; Weiss SFT
    BMC Cancer; 2018 May; 18(1):602. PubMed ID: 29843646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of LRP/LR induces apoptosis in pancreatic cancer and neuroblastoma cells through activation of caspases.
    Chetty CJ; Ferreira E; Jovanovic K; Weiss SFT
    Exp Cell Res; 2017 Nov; 360(2):264-272. PubMed ID: 28899658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.
    Naidoo K; Malindisa ST; Otgaar TC; Bernert M; Da Costa Dias B; Ferreira E; Reusch U; Knackmuss S; Little M; Weiss SF; Letsolo BT
    PLoS One; 2015; 10(11):e0141618. PubMed ID: 26545108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-LRP/LR-specific antibody IgG1-iS18 impedes adhesion and invasion of pancreatic cancer and neuroblastoma cells.
    Rebelo TM; Chetty CJ; Ferreira E; Weiss SF
    BMC Cancer; 2016 Nov; 16(1):917. PubMed ID: 27884119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells.
    Munien C; Rebelo TM; Ferreira E; Weiss SF
    Exp Cell Res; 2017 Feb; 351(2):135-141. PubMed ID: 28118986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.
    Vania L; Morris G; Ferreira E; Weiss SFT
    BMC Cancer; 2021 Apr; 21(1):392. PubMed ID: 33836696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells.
    Bignoux MJ; Otgaar TC; Bernert M; Weiss SFT; Ferreira E
    FEBS Open Bio; 2023 Feb; 13(2):323-340. PubMed ID: 36579897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the non-integrin laminin receptor reduces cellular viability by inducing apoptosis in lung and cervical cancer cells.
    Moodley K; Weiss SF
    PLoS One; 2013; 8(3):e57409. PubMed ID: 23472084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patented therapeutic approaches targeting LRP/LR for cancer treatment.
    Vania L; Morris G; Otgaar TC; Bignoux MJ; Bernert M; Burns J; Gabathuse A; Singh E; Ferreira E; Weiss SFT
    Expert Opin Ther Pat; 2019 Dec; 29(12):987-1009. PubMed ID: 31722579
    [No Abstract]   [Full Text] [Related]  

  • 13. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor.
    Zuber C; Knackmuss S; Zemora G; Reusch U; Vlasova E; Diehl D; Mick V; Hoffmann K; Nikles D; Fröhlich T; Arnold GJ; Brenig B; Wolf E; Lahm H; Little M; Weiss S
    J Mol Biol; 2008 May; 378(3):530-9. PubMed ID: 18387633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity.
    Da Costa Dias B; Jovanovic K; Gonsalves D; Moodley K; Reusch U; Knackmuss S; Penny C; Weinberg MS; Little M; Weiss SF
    Sci Rep; 2013; 3():2702. PubMed ID: 24048171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
    Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
    Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-LRP/LR specific antibody IgG1-iS18 significantly impedes adhesion and invasion in early and late stage colorectal carcinoma cells.
    Vania L; Chetty CJ; Ferreira E; Weiss SFT
    Mol Med; 2016 Oct; 22():664-673. PubMed ID: 27611822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
    Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
    Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
    Chetty C; Khumalo T; Da Costa Dias B; Reusch U; Knackmuss S; Little M; Weiss SF
    PLoS One; 2014; 9(5):e96268. PubMed ID: 24798101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.